Combination of two cancer drugs make pancreatic tumors treatable with immunotherapy methods

https://medicalxpress.com/news/2022-02-combination-cancer-drugs-pancreatic-tumors.html

"sensitize mesenchymal pancreatic carcinomes for treatment with immune checkpoint inhibitors. This question was explored through experiments on mice transplanted with tumor cells of PDAC subtypes...  anti-PD-L1 immunotherapy improved the effect of the combination treatment with trametinib and nintedanib... may also have the potential to create anti-tumor immunity with other cancer types, resulting in improved therapeutic outcomes"

Related:

Pushing past pancreatic tumors' defenses

https://medicalxpress.com/news/2022-02-pancreatic-tumors-defenses.html

Drug factory implants eliminate ovarian, colorectal cancer in mice

https://medicalxpress.com/news/2022-03-drug-factory-implants-ovarian-colorectal.html